Denali Therapeutics (NASDAQ:DNLI) Sets New 12-Month Low Following Analyst Downgrade
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) hit a new 52-week low on Tuesday after Oppenheimer lowered their price target on the stock from $50.00 to $42.00. Oppenheimer currently has an outperform rating on the stock. Denali Therapeutics traded as low as $14.01 and last traded at $14.61, with a volume of 376874 shares. […]
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) hit a new 52-week low on Tuesday after Oppenheimer lowered their price target on the stock from $50.00 to $42.00. Oppenheimer currently has an outperform rating on the stock. Denali Therapeutics traded as low as $14.01 and last traded at $14.61, with a volume of 376874 shares. […]
